We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.1B
AUM Growth
+$269M
Cap. Flow
-$141M
Cap. Flow %
-1.39%
Top 10 Hldgs %
9.04%
Holding
817
New
56
Increased
354
Reduced
285
Closed
43

Top Buys

Rank Stock Value
1
EXPO icon
Exponent
EXPO
+$35M
2
MMS icon
Maximus
MMS
+$21.2M
3
JBTM
JBT Marel
JBTM
+$18.4M
4
RLI icon
RLI Corp
RLI
+$16.7M
5
BBSI icon
Barrett Business Services
BBSI
+$16.6M

Top Sells

Rank Stock Value
1
FORM icon
FormFactor
FORM
+$60.8M
2
MKSI icon
MKS Inc
MKSI
+$48.2M
3
AAOI icon
Applied Optoelectronics
AAOI
+$35.3M
4
FTAI icon
FTAI Aviation
FTAI
+$30.6M
5
SII
Sprott
SII
+$28.9M

Sector Composition

Rank Sector Weight
1 Industrials 26.3%
2 Technology 18.47%
3 Financials 15.89%
4 Consumer Discretionary 13.13%
5 Healthcare 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIBN icon
476
SI-BONE Inc
SIBN
$861M
$4.69M 0.05%
371,082
+75,015
+25% +$1.17M
HTH icon
477
Hilltop Holdings
HTH
$2.21B
$4.64M 0.05%
129,540
-158,700
-55% -$5.82M
CRD.A icon
478
Crawford & Co Class A
CRD.A
$622M
$4.63M 0.05%
464,824
+222,788
+92% +$2.33M
UFPT icon
479
UFP Technologies
UFPT
$2.32B
$4.62M 0.05%
+23,867
New +$5.53M
PAYS icon
480
Paysign
PAYS
$743M
$4.59M 0.05%
778,183
ARQ icon
481
Arq
ARQ
$96.1M
$4.48M 0.04%
1,748,444
+290,000
+20% +$929K
CNXN icon
482
PC Connection
CNXN
$2.03B
$4.46M 0.04%
76,267
-3,021
-4% -$181K
DFTX
483
Definium Therapeutics
DFTX
$5.89B
$4.42M 0.04%
234,051
+70,010
+43% +$1.19M
INVE icon
484
Identive
INVE
$68.1M
$4.35M 0.04%
1,176,540
+100,436
+9% +$338K
LFMD icon
485
LifeMD
LFMD
$157M
$4.34M 0.04%
1,201,651
+292,000
+32% +$1.01M
LTRX icon
486
Lantronix
LTRX
$281M
$4.33M 0.04%
+826,326
New +$5.05M
CXDO icon
487
Crexendo
CXDO
$213M
$4.3M 0.04%
+697,062
New +$4.58M
KRUS icon
488
Kura Sushi USA
KRUS
$562M
$4.26M 0.04%
61,014
-10,001
-14% -$671K
CCB icon
489
Coastal Financial
CCB
$714M
$4.24M 0.04%
55,680
-68,172
-55% -$6.16M
UL icon
490
Unilever
UL
$139B
$4.22M 0.04%
74,000
+15,334
+26% +$1.03M
GILD icon
491
Gilead Sciences
GILD
$185B
$4.04M 0.04%
29,000
-13,500
-32% -$1.89M
HAE icon
492
Haemonetics
HAE
$4.78B
$4.03M 0.04%
71,475
TNC icon
493
Tennant Co
TNC
$1.19B
$3.98M 0.04%
60,000
+20,000
+50% +$1.45M
WGO icon
494
Winnebago Industries
WGO
$859M
$3.98M 0.04%
128,390
-113,230
-47% -$4.72M
ASUR icon
495
Asure Software
ASUR
$259M
$3.97M 0.04%
461,329
+170,586
+59% +$1.51M
SMRT icon
496
SmartRent
SMRT
$261M
$3.94M 0.04%
2,624,571
+190,000
+8% +$321K
PVLA
497
Palvella Therapeutics
PVLA
$2.17B
$3.93M 0.04%
31,507
+1,497
+5% +$156K
PPIH
498
Perma-Pipe International
PPIH
$221M
$3.9M 0.04%
130,941
-18,312
-12% -$564K
FLEX icon
499
Flex
FLEX
$42.6B
$3.9M 0.04%
59,556
-55,923
-48% -$3.58M
CIX icon
500
Comp X International
CIX
$393M
$3.88M 0.04%
166,074

Similar funds

Royce & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Royce & Associates held 817 positions worth $10.1B, up 2.7% from $9.86B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Royce & Associates's Q1 2026 filing shows 56 new, 354 increased, 285 reduced and 43 closed positions. Its largest new stake was Azenta: 523,308 shares worth $11.1M. The largest sale was FormFactor, an estimated $60.8M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q1 2026 buy was Azenta: 523,308 shares worth $11.1M.
  • Royce & Associates added most to Exponent in Q1 2026, an estimated $35M increase.
  • Royce & Associates's biggest Q1 2026 reduction was FormFactor, cutting an estimated $60.8M.
  • Royce & Associates fully exited TEGNA Inc in Q1 2026, selling an estimated $27.8M.
  • Royce & Associates's ten largest holdings make up 9% of its $10.1B portfolio in Q1 2026.
  • Royce & Associates opened 56 new positions and closed 43 in Q1 2026.
  • Royce & Associates's portfolio value rose 2.7% quarter-over-quarter to $10.1B.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.